BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 21832048)

  • 1. Identification of N-terminal extracellular domain determinants in nicotinic acetylcholine receptor (nAChR) α6 subunits that influence effects of wild-type or mutant β3 subunits on function of α6β2*- or α6β4*-nAChR.
    Dash B; Bhakta M; Chang Y; Lukas RJ
    J Biol Chem; 2011 Nov; 286(44):37976-37989. PubMed ID: 21832048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of rare variations reveals roles of amino acid residues in the N-terminal extracellular domain of nicotinic acetylcholine receptor (nAChR) alpha6 subunit in the functional expression of human alpha6*-nAChRs.
    Dash B; Li MD
    Mol Brain; 2014 May; 7():35. PubMed ID: 24886653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles for N-terminal extracellular domains of nicotinic acetylcholine receptor (nAChR) β3 subunits in enhanced functional expression of mouse α6β2β3- and α6β4β3-nAChRs.
    Dash B; Li MD; Lukas RJ
    J Biol Chem; 2014 Oct; 289(41):28338-51. PubMed ID: 25028511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of gain-of-function α6*-nicotinic acetylcholine receptor by β3 subunits.
    Dash B; Lukas RJ
    J Biol Chem; 2012 Apr; 287(17):14259-69. PubMed ID: 22315221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reporter mutation studies show that nicotinic acetylcholine receptor (nAChR) α5 Subunits and/or variants modulate function of α6*-nAChR.
    Dash B; Chang Y; Lukas RJ
    J Biol Chem; 2011 Nov; 286(44):37905-37918. PubMed ID: 21873428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of recombinant, α2*, α3* or α4*-nicotinic acetylcholine receptor (nAChR) function by nAChR β3 subunits.
    Dash B; Bhakta M; Chang Y; Lukas RJ
    J Neurochem; 2012 May; 121(3):349-61. PubMed ID: 22309577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biophysical and pharmacological characterization of α6-containing nicotinic acetylcholine receptors expressed in HEK293 cells.
    Rasmussen AH; Strøbæk D; Dyhring T; Jensen ML; Peters D; Grunnet M; Timmermann DB; Ahring PK
    Brain Res; 2014 Jan; 1542():1-11. PubMed ID: 24157862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular determinants of α-conotoxin potency for inhibition of human and rat α6β4 nicotinic acetylcholine receptors.
    Hone AJ; Talley TT; Bobango J; Huidobro Melo C; Hararah F; Gajewiak J; Christensen S; Harvey PJ; Craik DJ; McIntosh JM
    J Biol Chem; 2018 Nov; 293(46):17838-17852. PubMed ID: 30249616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of nigrostriatal alpha 6-containing nicotinic acetylcholine receptors is selectively reduced, but not eliminated, by beta 3 subunit gene deletion.
    Gotti C; Moretti M; Clementi F; Riganti L; McIntosh JM; Collins AC; Marks MJ; Whiteaker P
    Mol Pharmacol; 2005 Jun; 67(6):2007-15. PubMed ID: 15749993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta3 subunits promote expression and nicotine-induced up-regulation of human nicotinic alpha6* nicotinic acetylcholine receptors expressed in transfected cell lines.
    Tumkosit P; Kuryatov A; Luo J; Lindstrom J
    Mol Pharmacol; 2006 Oct; 70(4):1358-68. PubMed ID: 16835356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stable expression and functional characterization of a human nicotinic acetylcholine receptor with α6β2 properties: discovery of selective antagonists.
    Capelli AM; Castelletti L; Chen YH; Van der Keyl H; Pucci L; Oliosi B; Salvagno C; Bertani B; Gotti C; Powell A; Mugnaini M
    Br J Pharmacol; 2011 May; 163(2):313-29. PubMed ID: 21232042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elucidation of molecular impediments in the α6 subunit for in vitro expression of functional α6β4* nicotinic acetylcholine receptors.
    Jensen AB; Hoestgaard-Jensen K; Jensen AA
    J Biol Chem; 2013 Nov; 288(47):33708-33721. PubMed ID: 24085295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Orphan" alpha6 nicotinic AChR subunit can form a functional heteromeric acetylcholine receptor.
    Gerzanich V; Kuryatov A; Anand R; Lindstrom J
    Mol Pharmacol; 1997 Feb; 51(2):320-7. PubMed ID: 9203638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extending the analysis of nicotinic receptor antagonists with the study of alpha6 nicotinic receptor subunit chimeras.
    Papke RL; Dwoskin LP; Crooks PA; Zheng G; Zhang Z; McIntosh JM; Stokes C
    Neuropharmacology; 2008 Jun; 54(8):1189-200. PubMed ID: 18448138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positional scanning mutagenesis of α-conotoxin PeIA identifies critical residues that confer potency and selectivity for α6/α3β2β3 and α3β2 nicotinic acetylcholine receptors.
    Hone AJ; Ruiz M; Scadden M; Christensen S; Gajewiak J; Azam L; McIntosh JM
    J Biol Chem; 2013 Aug; 288(35):25428-25439. PubMed ID: 23846688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incorporation of the beta3 subunit has a dominant-negative effect on the function of recombinant central-type neuronal nicotinic receptors.
    Broadbent S; Groot-Kormelink PJ; Krashia PA; Harkness PC; Millar NS; Beato M; Sivilotti LG
    Mol Pharmacol; 2006 Oct; 70(4):1350-7. PubMed ID: 16822928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of AN6001, a positive allosteric modulator of α6β2-containing nicotinic acetylcholine receptors.
    van Hout M; Klein J; Ahring PK; Brown DT; Thaneshwaran S; Dos Santos AB; Jensen AA; Kohlmeier KA; Christophersen P; Dyhring T
    Biochem Pharmacol; 2020 Apr; 174():113788. PubMed ID: 31887290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. α-Conotoxin PeIA[S9H,V10A,E14N] potently and selectively blocks α6β2β3 versus α6β4 nicotinic acetylcholine receptors.
    Hone AJ; Scadden M; Gajewiak J; Christensen S; Lindstrom J; McIntosh JM
    Mol Pharmacol; 2012 Nov; 82(5):972-82. PubMed ID: 22914547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. α-Conotoxin VnIB from Conus ventricosus is a potent and selective antagonist of α6β4* nicotinic acetylcholine receptors.
    van Hout M; Valdes A; Christensen SB; Tran PT; Watkins M; Gajewiak J; Jensen AA; Olivera BM; McIntosh JM
    Neuropharmacology; 2019 Oct; 157():107691. PubMed ID: 31255696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of nicotinic acetylcholine receptor subunits in fetal and neonatal mouse thymus.
    Kuo Y; Lucero L; Michaels J; DeLuca D; Lukas RJ
    J Neuroimmunol; 2002 Sep; 130(1-2):140-54. PubMed ID: 12225896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.